These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1933581)

  • 1. Short-term course of 1,25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis.
    Geusens P; Vanderschueren D; Verstraeten A; Dequeker J; Devos P; Bouillon R
    Calcif Tissue Int; 1991 Sep; 49(3):168-73. PubMed ID: 1933581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis.
    Caniggia A; Nuti R; Galli M; Loré F; Turchetti V; Righi GA
    Calcif Tissue Int; 1986 Jun; 38(6):328-32. PubMed ID: 3089554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
    van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
    Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
    Duque G; Macoritto M; Dion N; Ste-Marie LG; Kremer R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E723-30. PubMed ID: 15572658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.
    Hartwell D; Riis BJ; Christiansen C
    Calcif Tissue Int; 1990 Dec; 47(6):332-7. PubMed ID: 2292078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow.
    Erben RG; Scutt AM; Miao D; Kollenkirchen U; Haberey M
    Endocrinology; 1997 Nov; 138(11):4629-35. PubMed ID: 9348188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.
    Marie PJ; Travers R
    Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 24,25-dihydroxyvitamin D3 in osteoclasts.
    Matsumoto T; Yamato H; Okazaki R; Kumegawa M; Ogata E
    Proc Soc Exp Biol Med; 1992 Jun; 200(2):161-4. PubMed ID: 1579577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
    Brixen K; Kassem M; Nielsen HK; Loft AG; Flyvbjerg A; Mosekilde L
    J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of short course of 1,25-dihydroxyvitamin D3 on biochemical markers of bone remodelling in postmenopausal women.
    Sirtori P; Sosio C; Resmini G; Rubinacci A
    Pharmacol Res; 1996 Jun; 33(6):353-9. PubMed ID: 8971958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic juvenile osteoporosis: evidence of normal osteoblast function by 1,25-dihydroxyvitamin D3 stimulation test.
    Bertelloni S; Baroncelli GI; Di Nero G; Saggese G
    Calcif Tissue Int; 1992 Jul; 51(1):20-3. PubMed ID: 1393771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.
    Hodsman AB; Fraher LJ
    Bone Miner; 1990 May; 9(2):137-52. PubMed ID: 2161692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients.
    Mortensen BM; Aarseth HP; Ganss R; Haug E; Gautvik KM; Gordeladze JO
    Bone; 1993; 14(2):125-31. PubMed ID: 8334029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women.
    Duda RJ; Kumar R; Nelson KI; Zinsmeister AR; Mann KG; Riggs BL
    J Clin Invest; 1987 Apr; 79(4):1249-53. PubMed ID: 3494046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
    Cosman F; Nieves J; Shen V; Lindsay R
    J Bone Miner Res; 1995 Apr; 10(4):594-600. PubMed ID: 7610930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.